INVA Q1 2021 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$86M+8.7% YoY

Gross Profit

$85M99.9% margin

Operating Income

$79M92.9% margin

Net Income

$94M110.1% margin

EPS (Diluted)

$0.84

QoQ Revenue Growth

-5.5%

Cash Flow

Operating Cash Flow

$84M

Free Cash Flow

$84M

Stock-Based Comp.

$451,000

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$392M

Stockholders' Equity

$634M

Cash & Equivalents

$283M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86M	$79M	+8.7%
Gross Profit	$85M	$79M	+8.6%
Operating Income	$79M	$76M	+4.4%
Net Income	$94M	$65M	+43.8%